-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/invest-in-trust-guide.pdf
May 01, 2021 - And I know they had
to do it because of the
circumstances, we’re in a
pandemic, a crisis situation … initial EUA, but the
FDA and CDC share the
responsibility of active
post-authorization vaccine
monitoring … and doctors)
47%
CDC 44%
“My family” 39%
FDA 33%
Federal government agencies responsible for
monitoring
-
www.ahrq.gov/sites/default/files/wysiwyg/nursing-home/materials/invest-in-trust-guide.pdf
May 01, 2021 - And I know they had
to do it because of the
circumstances, we’re in a
pandemic, a crisis situation … initial EUA, but the
FDA and CDC share the
responsibility of active
post-authorization vaccine
monitoring … and doctors)
47%
CDC 44%
“My family” 39%
FDA 33%
Federal government agencies responsible for
monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
September 29, 2014 - guideline recommends not a dose ceiling, per
se, but rather an amount for which “more frequent and intense monitoring … Decisionmaking section, the first paragraph
seems to represent an accurate description of the current situation … misuse in
patients prior to initiating opioid
therapy (the COMM and others have
been evaluated for monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
September 29, 2014 - guideline recommends not a dose ceiling, per
se, but rather an amount for which “more frequent and intense monitoring … Decisionmaking section, the first paragraph
seems to represent an accurate description of the current situation … misuse in
patients prior to initiating opioid
therapy (the COMM and others have
been evaluated for monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - from a single intravenous dose at
8 hours cannot be assumed to represent
results for every other situation … The
differences in analgesic types, doses and
durations of treatment are highly specific
to the situation … 93
differences in analgesic types, doses and
durations of treatment are highly specific
to the situation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
December 29, 2020 - from a single intravenous dose at
8 hours cannot be assumed to represent
results for every other situation … The
differences in analgesic types, doses and
durations of treatment are highly specific
to the situation … 93
differences in analgesic types, doses and
durations of treatment are highly specific
to the situation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - post-treatment
symptoms, psychosocial concerns, employment
and insurance difficulties), education and
monitoring … For example, patients with DCIS
may not need ongoing monitoring by an oncology
specialist after a short … patient
specific variables, I would think that the PCP
could have responsibilities for wellness and
monitoring … for new cancer, while the oncologist
could have responsibilities for disease monitoring
and late effect … monitoring.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
March 18, 2014 - post-treatment
symptoms, psychosocial concerns, employment
and insurance difficulties), education and
monitoring … For example, patients with DCIS
may not need ongoing monitoring by an oncology
specialist after a short … patient
specific variables, I would think that the PCP
could have responsibilities for wellness and
monitoring … for new cancer, while the oncologist
could have responsibilities for disease monitoring
and late effect … monitoring.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Considering the Range of Decision-Relevant Effects
Choosing the Important Outcomes for a Systematic Review of a Medical Test
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Choosing the Important Outcomes for a Systematic Revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Considering the Range of Decision-Relevant Effects
Choosing the Important Outcomes for a Systematic Review of a Medical Test
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Choosing the Important Outcomes for a Systematic Revi…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Considering the Range of Decision-Relevant Effects
Choosing the Important Outcomes for a Systematic Review of a Medical Test
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Choosing the Important Outcomes for a Systematic Revi…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-choosing-outcomes.ppt
June 01, 2012 - Considering the Range of Decision-Relevant Effects
Choosing the Important Outcomes for a Systematic Review of a Medical Test
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Medical Test Reviews Methods Guide
www.ahrq.gov
Choosing the Important Outcomes for a Systematic Revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - This situation can arise from, for instance, variation in
the completeness of data, differential blinding … Were the methods used for monitoring adverse effects reported, such as use of
prospective or routine … monitoring; spontaneous reporting; patient checklist, questionnaire
or diary; systematic survey of
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
June 02, 2011 - This situation can arise from, for instance, variation in
the completeness of data, differential blinding … Were the methods used for monitoring adverse effects reported, such as use of
prospective or routine … monitoring; spontaneous reporting; patient checklist, questionnaire
or diary; systematic survey of
-
www.ahrq.gov/sites/default/files/publications/files/cuspsuccess.pdf
October 01, 2012 - By
monitoring and keeping quality and safety initiatives in front of key organizational stakeholders
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs021496-jackson-final-report-2019.pdf
January 01, 2019 - visit, two research team members conducted a semi-structured interview
including questions on living situation … involved: 1) illness
work includes tasks directly related to the illness (e.g., taking medications, monitoring … conditions), pregnancy seemed to
demand fewer traditional forms of illness work, such as medications and monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/telehealth-women-draft-report.pdf
December 10, 2021 - involving a clinician across distance or time, such as
remote real-time clinical visits and remote monitoring … to preventive services and reproductive health care to include telehealth for remote
counseling or monitoring … involving a clinician
across distance or time, such as remote real-time clinical visits and remote monitoring … outcome with telehealth
*Function categories are prevention, screening, counseling, treatment, remote monitoring … Mobile remote monitoring of
intimate partner violence among
pregnant patients during the COVID-
19
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/prevention-chronic-care/resources/ccrm-atlas-suppl/ccrm-atlas-suppl.pdf
October 01, 2013 - Support may include clinician involvement in the
development, implementation, and monitoring of a prevention … Support may include
community resource involvement in the development, implementation, and
monitoring
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/publications/files/ccrm-atlas-suppl.pdf
October 01, 2013 - Support may include clinician involvement in the
development, implementation, and monitoring of a prevention … Support may include
community resource involvement in the development, implementation, and
monitoring
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
May 01, 2015 - HIEs right now are
allowing pediatric primary care providers to monitor
student blood glucose monitoring